Nearly half of women receiving a COVID-19 vaccine reported heavier menstrual bleeding, according to new research from the University of Illinois at Urbana-Champaign.
The figures come from a survey of over 35,000 women who were fully vaccinated, with the majority of the cohort receiving a Pfizer jab followed by Moderna.
“In this sample, 42% of people with regular menstrual cycles bled more heavily than usual, while 44% reported no change after being vaccinated,” summarized researchers, which counted funding from the National Institutes of Health (NIH) for the study.
“Respondents reported noticing changes to their period 1 to 7 days after vaccines (dose 1: 31.4%; dose 2: 37.0%), 8 to 14 days after vaccines (dose 1: 25.9%; dose 2: 23.6%), or more than 14 days after receiving their vaccines (dose 1: 29.9%; dose 2: 26.8%), with the rest of respondents reporting that they were menstruating when they received the vaccine (dose 1: 12.7%; dose 2: 12.5%),” explained the study.
In sum, 42.1 percent of women reported experiencing a heavier menstrual flow after receiving the COVID-19 vaccine, 14.3 percent reported a mix of lighter or no change, and 43.6 percent reported no change in flow.
The new study, “Investigating Trends in Those who Experience Menstrual Bleeding Changes After SARS-CoV-2 Vaccination,” was published in the journal Science Advances. Another study funded by the NIH found that COVID-19 vaccines had the potential to lengthen women’s menstrual cycles, as well.
The side effects of the “vaccines” – which have been dismissed by mainstream media outlets and social media fact-checkers as untrue – follows lobbying efforts on behalf of pharmaceutical giants Pfizer and Moderna reaching record-high levels of spending and overall personnel hired. The massive lobbying campaigns are likely responsible for nationwide vaccine mandates, which have subsequently been struck down by district courts.
Similarly, posing another conflict of interest, the chairman and former Chief Executive Officer (CEO) of the Thomson Reuters Foundation – James C. Smith – is a top investor and board member for pharmaceuticals giant Pfizer.
At the time of publication, Reuters has not covered the University of Illinois at Urbana-Champaign study.
The outlet, however, has run stories titled “Vaccines not linked to menstrual changes; COVID, flu shots can go together” and “No link found between menstrual changes and COVID vaccines.”
The study also follows researchers concluding that Pfizer’s COVID-19 vaccine resulted in a sustained loss in sperm count and could pose a risk to heart health, especially among young men, despite mockery by mainstream media outlets over the concerns.
